AppYea Inc (PK:APYP)

Mar 20, 2024 11:45 am ET
AppYea Launches E-Commerce Store on Amazon Broadening Distribution
GAN YAVNE, ISRAEL / ACCESSWIRE / March 20, 2024 / AppYea, Inc. (OTCQB:APYP), developer of an innovative and accurate wearable monitoring solution to treat sleep apnea and snoring, today announced the launch of its new e-commerce store on Amazon.
Jan 10, 2024 09:30 am ET
Dec 13, 2023 06:20 am ET
AppYea Provides Year-End Letter to Shareholders Recapping Key Achievements and Sharing Outlook for 2024
GAN YAVNE, ISRAEL / ACCESSWIRE / December 13, 2023 / AppYea Inc. (OTCQB:APYP), focusing on the development of accurate wearable monitoring solutions to treat sleep apnea and snoring, today provided the following letter to shareholder from the Company's CEO, Adi Shemer:
Aug 28, 2023 09:35 am ET
AppYea Secures US Patent for Innovative Sleep Apnea Detection Using Speech Analysis
New Patent Promises Affordable and Convenient Sleep Apnea Diagnostics; Market Projected to Reach US$ 9.27 Billion by 2033
Aug 03, 2023 09:20 am ET
AppYea Announces Equity Financing Transaction to Accelerate Commercial Launch
Transaction expected to streamline capital structure and ultimately result in the elimination of all Company debt
Jul 31, 2023 09:30 am ET
AppYea Announces Appointment of Leading Medical Device Industry Executive Adi Shemer as CEO
GAN YAVNE, ISRAEL / ACCESSWIRE / July 31, 2023 / AppYea Inc. (OTC:APYP), which is focused on the development of accurate wearable monitoring solutions to treat sleep apnea and snoring, today announced the appointment of Adi Shemer as Chief Executive Officer of the Company. Mr. Shemer has been working with the Company since February 2023 as a member of the advisory board.
Feb 16, 2023 09:25 am ET
Leading Operations Executive Adi Shemer Joins AppYea's Advisory Board
GAN YAVNE, ISRAEL / February 16, 2023 / AppYea Inc. (OTCQB:APYP), a developer of accurate wearable monitoring solutions to treat sleep apnea and snoring, is pleased to announce the addition of Adi Shemer to the advisory board of the Company, effective immediately.
Jan 23, 2023 09:05 am ET
Ron Mekler Joins AppYea's Board of Directors Audit Committee Chair
GAN YAVNE, ISRAEL / ACCESSWIRE / January 23, 2023 / AppYea Inc. (OTCQB:APYP) which focuses on the development of accurate wearable monitoring solutions to treat sleep apnea and snoring, is pleased to announce the addition of Ron Mekler as an independent director of the Company and Chair of the Audit Committee, effective immediately.
Nov 29, 2022 12:59 pm ET
SleepX has Started Marketing its Flagship Product, DreamIT - an AI-Based Wristband to Treat the Snoring Problem Through Biofeedback
In the first phase, DreamIT will be available to Android users and delivery of the first devices to customers is expected by the end of the year.
Feb 21, 2019 06:30 am ET
AppYea, Inc. Engages Smalltell, a Social Commerce and Design Company
via NEWMEDIAWIRE -- AppYea, Inc. (OTCPK:APYP, or the "Company"), announced today that the company has engaged Smalltell (Smalltell.com) to develop a new website and marketing strategy for its new CBD based line of products.  Smalltell will also...
Feb 19, 2019 06:30 am ET
AppYea, Inc. Fulfills First CBD Purchase Order
via NEWMEDIAWIRE -- AppYea, Inc. (OTCPK:APYP, or the "Company"), which previously announced its move into Hemp based CBD infused products, announced today that the company has received and fulfilled its first purchase order from Hempori, Inc....
Feb 14, 2019 06:00 am ET
AppYea, Inc. Signs Exclusive CBD Infused Beverage Licensing Agreement
via NEWMEDIAWIRE -- AppYea, Inc. (OTCPK:APYP, or the "Company") is pleased to announce that is has entered into an exclusive CBD infused beverage licensing agreement with Prouty Company, Inc. (“ProutyCo”). The CBD infused beverage product line in...
Feb 06, 2019 06:30 am ET
AppYea, Inc. Enters into CBD Distribution Agreement
via NEWMEDIAWIRE – Appyea, Inc. (OTCPK: APYP, or the "Company") is pleased to announce that is has entered into a distribution agreement with Dallas, TX based Hempori, Inc. (“Hempori”) which will allow Appyea, Inc. to source new CBD based products...
Jan 29, 2019 06:30 am ET
AppYea, Inc. Enters into Management Agreement with Hempori, Inc.
via NEWMEDIAWIRE -- AppYea, Inc. (OTCPK: APYP, or the "Company") is pleased to announce that is has entered into a management agreement with Dallas, TX based management company Hempori, Inc. (“Hempori”) which will assist the Company in identifying...
Nov 28, 2017 07:30 am ET
AppYea Signs Sales and Marketing Agreement with Syncier BioTech
AppYea, Inc, (OTC PINK: APYP) announced today that its subsidiary, The Diagnostic Centers, has entered into a sales and Marketing Agreement with Syncier BioTech Inc. to strengthen its Pharmacogenetic ("PGx") testing capabilities and service offerings.
Nov 02, 2017 07:30 am ET
AppYea's Subsidiary The Diagnostic Centers Signs First New Client
AppYea Inc. (OTC PINK: APYP) announced today that its subsidiary The Diagnostic Centers has signed its first new client, Pacific Pain & Regenerative Medicine, with locations in Los Angeles and Irvine, California and has started shipping PGx samples for testing.
Oct 17, 2017 08:00 am ET
AppYea Launches Three New Apps on Google Play
AppYea Inc (OTC PINK: APYP) announced today that it has released two new gaming apps and one pharmaceutical savings app on Google Play for the Android systems and will soon release the games on Apple's iTunes for the iPhone and iOS Platform.
Sep 20, 2017 07:30 am ET
AppYea Announces Sales and Marketing Team for Its Diagnostic Centers Inc.
APPYEA Inc. (OTC PINK: APYP) announced on August 14th, 2017 that it formed a new subsidiary, The Diagnostic Centers Inc., to focus on marketing certain products and services to healthcare providers.
Aug 17, 2017 08:30 am ET
AppYea Announces New Diagnostic Division
APPYEA, Inc. (OTC PINK: APYP) announced today that it has created a new diagnostic division and incorporated a wholly owned subsidiary named The Diagnostic Centers Inc. The subsidiary company will focus on marketing certain products and services to healthcare providers as previously announced in a prior Form 8-K filing with the SEC, which included the following disclosure:
Apr 28, 2016 06:06 pm ET
AppYea Falls Victim to Elaborate Fraud
APPYEA Inc. (OTCQB: APYP), a fully reporting company, announced today that the Company has fallen victim to an elaborate fraud. On April 19, 2016, an as yet unidentified party issued a fraudulent press release claiming that AppYea had entered into a...
Apr 20, 2016 11:59 am ET
KILL - AppYea Announces LOI to Acquire Intellectsoft Through Stock Purchase Agreement
Editors and other readers are advised to disregard the news release with the headline, "AppYea Announces LOI to Acquire Intellectsoft Through Stock Purchase Agreement," issued Tuesday, April 19, 2016. The release contained erroneous information...
Apr 19, 2016 09:15 am ET
AppYea Announces LOI to Acquire Intellectsoft Through Stock Purchase Agreement
AppYea Inc (OTCQB: APYP) is pleased to announce a letter of intent to acquire Intellectsoft, a leading developer and manufacturer of software applications with a major global footprint. AppYea has come to an understanding to purchase all the...

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.